Establishment Labs Holdings (ESTA) Return on Capital Employed Growth (1y) (2019 - 2026)
Establishment Labs Holdings (ESTA) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 125.00 |
| 10 | Establishment Labs Holdings | 2.75 Bn | 2.68 Bn | 42.34 Mn | 1,089.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,089.00 |
| Dec 31, 2025 | 561.00 |
| Sep 30, 2025 | 240.00 |
| Jun 30, 2025 | -69.00 |
| Mar 31, 2025 | 626.00 |
| Dec 31, 2024 | 1,033.00 |
| Sep 30, 2024 | 174.00 |
| Jun 30, 2024 | -206.00 |
| Mar 31, 2024 | -266.00 |
| Dec 31, 2023 | -588.00 |
| Sep 30, 2023 | -241.00 |
| Jun 30, 2023 | 297.00 |
| Mar 31, 2023 | 248.00 |
| Dec 31, 2022 | -229.00 |
| Sep 30, 2022 | -236.00 |
| Jun 30, 2022 | -1,142.00 |
| Mar 31, 2022 | -1,029.00 |
| Dec 31, 2021 | -90.00 |
| Mar 31, 2021 | 799.00 |
| Dec 31, 2020 | 1,133.00 |